Drug Delivery Devices Market Size | Market Overview & Forecast

Q: What is the overall size of the drug delivery devices market?

The drug delivery devices market is projected to reach USD 66.1 billion by 2031.

Q: What technologies are being used in modern drug delivery devices?

Technologies such as microneedles, smart injectors, transdermal patches, and biodegradable implants are becoming widely adopted.

Q: What is the compound annual growth rate for the market?

The market is expected to grow at a CAGR of 7.6% over the forecast period.

Q: Which medical conditions are most commonly treated using drug delivery devices?

Chronic illnesses like diabetes, cancer, asthma, and autoimmune diseases are major therapeutic areas using drug delivery devices.

Q: What regions are expected to lead the market in the coming years?

North America and Europe are expected to lead, while Asia-Pacific is emerging due to increased healthcare investment and aging demographics.

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Code: MTA4843

Publication Date: Jul 2025

What is the Drug Delivery Devices Market Size?

According to 6Wresearch internal database and industry insights, the Global drug delivery devices market was valued at USD 39.6 billion in 2024 and is projected to reach USD 66.1 billion by 2031, growing at a CAGR of 7.6% during the forecast period.

This growth is driven by the rising prevalence of chronic diseases, growing elderly population, and technological innovations that improve targeted and controlled drug delivery. The demand for self-administration devices and the shift toward minimally invasive treatment methods are also contributing to market expansion.

Key Growth Factors of the Drug Delivery Devices Market

Growing demand for self-administered and home-based treatment devices
Rise in chronic diseases such as diabetes, cancer, and respiratory disorders
Technological advances enabling controlled, sustained, and targeted drug release
Increasing geriatric population requiring long-term drug therapies
Development of biologics and biosimilars needing specialized delivery systems
Expanding investment in smart, wearable, and needle-free drug delivery technologies

Drug Delivery Devices Market Trends

Smart drug delivery devices equipped with sensors and wireless connectivity are being developed for real-time monitoring. Needle-free injectors and inhalers are gaining popularity for improved patient compliance. 3D printing is increasingly being explored to manufacture patient-specific drug devices. There is a growing focus on biodegradable implants for sustained drug delivery with fewer side effects.

Emerging Developments in the Drug Delivery Devices Market

Microneedle patches for painless transdermal delivery are under active research. Integration of AI and data analytics into wearable injectors is enhancing therapy personalization. Companies are also developing multifunctional delivery platforms combining diagnostics and therapeutics. Biodegradable polymers are being explored for implantable and oral delivery applications. Regulatory bodies are fast-tracking approvals of innovative devices to meet patient-centric needs.